FREDERICK MIN, MD
Hematology & Oncology Physician · SILVER SPRING, MD
Individual Active NPI 1366682429
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 735 | 324,038 | $23,442,871 | $7,206,943 | $5,747,719 |
| 2023 | 804 | 365,199 | $23,413,728 | $6,680,248 | $5,318,504 |
| 2022 | 683 | 428,400 | $25,541,791 | $7,372,410 | $5,884,007 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 72,900 | $3 | $2 |
| J9271 | Injection, pembrolizumab, 1 mg | 32,000 | $55 | $44 |
| J0897 | Injection, denosumab, 1 mg | 16,980 | $25 | $20 |
| Q5110 | Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 16,320 | $0 | $0 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 15,300 | $0 | $0 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 11,880 | $48 | $38 |
| J0185 | Injection, aprepitant, 1 mg | 9,750 | $2 | $1 |
| J1756 | Injection, iron sucrose, 1 mg | 8,200 | $0 | $0 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 5,300 | $0 | $0 |
| J9267 | Injection, paclitaxel, 1 mg | 5,004 | $0 | $0 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 4,050 | $0 | $0 |
| J1437 | Injection, ferric derisomaltose, 10 mg | 3,000 | $20 | $16 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | D68686 | MD |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Maryland
- NPI 1821822248
- NPI 1528892940
- NPI 1538499504
- NPI 1952338592
- NPI 1144557240
- NPI 1790919744
- NPI 1831695204
- NPI 1740396761
See all Hematology & Oncology Physician providers in Maryland →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.